Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD19/CD22 CAR T cells |
Trade Name | |
Synonyms | Autologous CD19/CD22 Chimeric Antigen Receptor T-cells |
Drug Descriptions |
CD19/CD22 CAR T cells are human T-cells engineered to express a CD19 and CD22 chimeric receptor, which may lead to cytotoxic immune response against tumor cells expressing CD19 and CD22 (PMID: 32005917). |
DrugClasses | CD19 Immune Cell Therapy 62 CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C142834 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD19/CD22 CAR T cells | CD19/CD22 CAR T cells | 0 | 8 |
CD19/CD22 CAR T cells + Cyclophosphamide + Fludarabine | CD19/CD22 CAR T cells Cyclophosphamide Fludarabine | 0 | 0 |